FSA bans directors for misusing client money

David Benyon
01 Oct 2008

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Regulation

LONDON - Three directors at insurance firm BPS Insure have been banned by the UK's Financial Services Authority (FSA) for failing to inform the regulator that BPS had run up a deficit of £3 million in its client account and had misused client funds.

BPS, which went into administration in 2005, was a small general insurance intermediary, specialising in non- investment insurance contracts for commercial and retail customers. The FSA said chief executive officer Robert James and directors Stewart Lawton and Paul Adams breached Principle 1 of the regulator's rulebook and had acted continually without integrity in knowingly failing to meet requirements, in particular using clients' money to pay general business expenses.

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You are currently on corporate access.